Get Price And Support

China Biotech Distributor Strategy Services BioPlan Associates

  • Biosimilars/Biobetters Pipeline Directory

    Jan 01, 2019 · Biosimilars Biogenerics Biobetters BIOPHARMA is about biopharmaceuticals pharmaceuticals biologics biotechnology drugs U.S. European therapeutics vaccines monoclonal antibodies biologics biocomparables generics follow-on proteins 505(b)2 approvals FDA EMEA EMA

    Get Support »
  • Costs, complexity and competition driving innovation in .

    Langer cited BioPlan Associates' 15 th Annual report to support his comments about productivity, explaining that, "The average titer for reported new commercial-scale monoclonal antibody (mAb) upstream bioprocessing was 3.20 g/L, up from 2.80 g/L last year.

    Get Support »
  • Pharmaceuticals consulting & Biotech consulting - Bain .

    Bain helps pharmaceutical manufacturers become more competitive and successful in today's evolving market—that means ensuring their products contribute to favorable and demonstrable outcomes, and streamline costs in the face of increasing price pressure.

    Get Support »
  • China Biopharmaceutical Growth Exceeding Western Projections

    Nov 28, 2018 · BioPlan – a strategy analysis firm based in Rockville, MD USA – has been assessing global growth of the biopharma and biotech industry for nearly 30 years, and this China expansion has been regularly tracked.

    Get Support »
  • Distributors - RayBiotech: Empowering Your Proteomics

    Click to view all RayBiotech Certified Service Providers. The distributors listed with this logo are service providers who have successfully completed RayBiotech's training and certification program for testing samples with our antibody array products.

    Get Support »
  • CMOs move toward disposable manufacturing tech | .

    Sep 24, 2012 · CMOs move toward disposable manufacturing tech. . with the company's development services, . researcher BioPlan Associates .

    Get Support »
  • Biotechnology/Pharmaceutical Services Outsourcing Market .

    Attribute. Details. Base year for market estimation. 2015. Actual estimates/Historic market data. 2014 - 2015. Forecast period. 2016 - 2025. Market representation

    Get Support »
  • China Pharmaceutical Company Directory 2018 - Research and .

    Jan 12, 2018 · China Pharmaceutical Company Directory 2018 - Research and Markets . This new edition of the China Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date .

    Get Support »
  • China Pharmaceutical Company Directory 2018 - Research and .

    Jan 12, 2018 · China Pharmaceutical Company Directory 2018 - Research and Markets . This new edition of the China Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date .

    Get Support »
  • CMOs move toward disposable manufacturing tech | .

    Sep 24, 2012 · CMOs move toward disposable manufacturing tech. . with the company's development services, . researcher BioPlan Associates .

    Get Support »
  • BioPlan Associates Releases New Report | BioPharm .

    Jun 29, 2015 · A wealth of new industry insight is now available, thanks to the release of BioPlan Associate's quantitative report, the 12 th Annual Report and Survey of Biomanufacturing.. The report finds that the worldwide pharmaceutical market is worth more than 200 billion and is doubling approximately every five years.

    Get Support »
  • Costs, complexity and competition driving innovation in .

    The ever present need for efficiency, combined with capacity constraints and interest in continuous manufacturing are changing what the pharmaceutical industry demands of its technology suppliers. This, in turn, is fostering innovation in the production technology sector according to industry experts.

    Get Support »
  • China's Healthcare Reforms Underscore Market Growth .

    Healthcare reform in China started in 2009 and is still ongoing, often with different goals each year. We summarize the major 2017 reforms below. Pre-Investment, Market Entry Strategy Advisory Services from Dezan Shira & Associates. The two invoices system for pharmaceutical distribution

    Get Support »
  • People Interviewed | American Pharmaceutical Review - The .

    He lectures extensively on marketing, pricing and channel management topics, and teaches at Johns Hopkins University and American University: Biotechnology Marketing, Marketing Management, Services Marketing, Advertising Strategy, and Bioscience Communication. In 1989 he co-founded BioPlan Associates, Inc.

    Get Support »
  • China Today: Pharmaceutical Distribution in China .

    The country strives to modernize its distribution logistics as thousands of small companies compete for profits China today represents a 15-billion market for pharmaceutical products.

    Get Support »
  • The next phase: Opportunities in China's pharmaceuticals .

    The next phase: Opportunities in China's pharmaceuticals market 3 1.2 Latest developments By 2010, the number of urban and rural residents covered by the basic medical insurance scheme had

    Get Support »
  • Trends and Growth in Single-Use System (SUS) Adoption .

    Oct 15, 2017 · BioPlan Associates has surveyed global biopharmaceutical manufacturers and CMOs to gain insight into current and future trends in the industry. In BioPlan's 14th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, we asked 227 bioprocessing decision-makers where they are using SUS and disposables, and the .

    Get Support »
  • China Medical Device - Accelerate Your Medical Device's .

    China Med Device - specialize in accelerating Western medtech companies with turn-key solutions for China FDA regulatory&CRO services and commercialization.

    Get Support »
  • 14th Annual Report and Survey of Biopharmaceutical .

    14th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production This comprehensive look at the state of worldwide biopharmaceutical manufacturing provides the only on-going assessment of manufacturing capacity and production in this 200 billion global industry.

    Get Support »
  • Biopharmaceutical Manufacturing | As Biopharma Matures .

    Apr 12, 2010 · As Biopharma Matures: Working Harder, Getting Leaner Chronic problems, including downstream costs, disposable equipment issues, and the need for real-time process monitoring, challenge growing manufacturers to keep in shape. By Eric Langer, BioPlan Associates.

    Get Support »
  • Contract BioManufacturing in China: Creating a New Segment

    Cai Yang is project manager at BioPlan Associates. He has business development experience in biotech and pharma segments and 10 years in market research and has worked with equipment manufacturers in pharmaceutical and medical device industries in Switzerland, Austria and Germany.

    Get Support »
  • Investment in Biopharma Facilities Continues

    Nov 04, 2016 · Biopharmaceutical manufacturers are also leveraging modular technology to reduce the time and cost of constructing new facilities. In November 2015, JHL Biotech's pre-fabricated KUBio plant manufactured by GE Healthcare Life Sciences was assembled from 62 containers in Wuhan, China.

    Get Support »
  • China Pharmaceuticals: A brighter future for fewer players

    About Social Media. DBS welcomes and encourages the sharing of content, ideas, and stories on social media sites. Links to share DBS content on third-party organisations' platforms are provided as a service to its readers/followers but should not be considered an endorsement of a site, product, or service.

    Get Support »
  • Manage Consolidation in the Distribution Channel

    In almost every business-to-business industry, companies are facing increasingly powerful intermediaries in their distribution channel. Industry consolidation is replacing a multitude of small "mom and pop" distributors with a handful of national, professionally managed, publicly traded corporations.

    Get Support »
  • 15th Annual Report and Survey of Biopharmaceutical .

    15th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production The 2018 15th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production.

    Get Support »
  • Pharmaceuticals Market Research Reports & Industry Analysis

    Pharmaceuticals Market Research Reports & Industry Analysis Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

    Get Support »
  • BIO OUTSOURCING ASIA - Open Biotech and Pharma .

    Bio Outsourcing Asia© TABLE OF CONTENTS October 2009 Vol. 2 Issue 3 . From BioPlan Associates Inc. The Middle East's Biotech Potential Faiz Kermani, PhD . turing, distribution, and other services. In addition to the park's facilities and infrastructure, DuBiotech also offers services such as regulatory affairs man- .

    Get Support »
  • Why US manufacturers are nixing the US for China - CNBC

    Sep 21, 2015 · Why US manufacturers are nixing the US for China . which has helped companies source products and services in China since 2002 and has offices in Houston and Shanghai. . JHL Biotech .

    Get Support »
  • Biosimilar Markets and Regulation: Which Countries Are .

    China is rapidly catching up and expected to surpass it over the next 5–10 years. Recent BioPlan Associates studies show that China has now largely caught up with India in capacity (total bioreactor volume), but it is growing much more rapidly as many new biogeneric (and some genuine biosimilar) developers enter the field (2, 3). These and .

    Get Support »
  • BIO OUTSOURCING ASIA - Open Biotech and Pharma .

    would be produced externally within a decade as part of his strategy of supply chain management, quality, and security of supply. AstraZeneca plans to increase its outsourcing drastically from both China and India. Chinese Biotech Growth The first Chinese biotech companies were mostly vaccine providers, as .

    Get Support »